Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Pharmacological and Toxicological Methods|June 8, 2024
Characterization of ascending dose canine telemetry model supports its use in E14/S7B QT integrated risk assessmentsAlysia A Chaves, Jude W Ferraro, Jing Yu, et al.
The Journal of Infectious Diseases|September 30, 2000
Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected childrenJ C Lindsey, M D Hughes, R E McKinney, et al.
The Journal of Infectious Diseases|December 1, 1996
After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study GroupE R Cooper, R P Nugent, C Diaz, et al.
The New England Journal of Medicine|August 5, 1999
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study GroupP M Garcia, L A Kalish, J Pitt, et al.
AIDS (London, England)|August 10, 2000
Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samplesD T Dunn, R J Simonds, M Bulterys, et al.
Medical Care|April 24, 2001
UPBEAT: the impact of a psychogeriatric intervention in VA medical centers. Unified Psychogeriatric Biopsychosocial Evaluation and TreatmentG Kominski, R Andersen, R Bastani, et al.
The New England Journal of Medicine|August 5, 1999
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 TeamL M Mofenson, J S Lambert, E R Stiehm, et al.
AIDS (London, England)|March 15, 2000
HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study GroupS L Welles, J Pitt, R Colgrove, et al.
AIDS Research and Human Retroviruses|August 24, 2000
Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study TeamA Wiznia, K Stanley, P Krogstad, et al.
The Journal of Infectious Diseases|November 9, 2000
Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study TeamW T Shearer, R J Israel, S Starr, et al.
Pageof 6